Proteomics Market - By Component (Instruments, Reagents, Services), By Application (Drug Discovery, Disease Diagnosis and Others) & Global Region - Market Size, Trends, Opportunity and Forecast 2020-2025Request Sample Request Discount
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Proteomics MarketRequest Sample
The proteomics market is likely to mask a CAGR of 14.9% during the projected period. Further, the market was deliberate at USD XXXX billion in 2019 and is anticipated to reach a valuation of USD XXXX billion by the end of the projected period. Proteomics was first coined by Marc Wilkins in 1996 to symbolize the protein complement of a genome which produced or modified by an organism or system. Proteomics is the study of protein structure in both active and inactive states of functional genomics and known as proteome.
Growth Drivers & Restrain:
The increasing vulnerable diseases such as, cancer, diabetes, and cardiovascular are the major factors, which are encouraging the demand for proteomics. The rising research and development activities in the areas of personalized medicine and drug discovery are projected to enhance the growth of the proteomics market in the near future. Moreover, the increasing pharmaceutical companies in drug discovery and biotechnology along with R&D expenditure on the development of proteomics are the key factors that are projected to encourage the growth of the proteomics market in upcoming years. Further, rising patient awareness regarding the early treatment of high-risk diseases is one of the major factors that have contributed to the growth of the proteomics market. Additionally, recent developments in the proteomics market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, and regional expansion of major participants involved in the proteomics market on a global and regional basis have fostered the market growth considerably throughout the globe. Furthermore, the availability of proteomics instruments such as microarray, chromatography, spectrometry, and others for measuring several genes, proteins, mass-to-charge ratio in a body in both developed and emerging market boosts the market growth of proteomics.
Moreover, improving healthcare infrastructure across the globe is one of the major factors that are positively influencing the growth of the proteomics market. Based on application, the proteomics market is segmented into drug discovery, clinical diagnostics, and other applications. The drug discovery segment is estimated to account for the largest market share in 2019. Proteomics technologies in drug discovery minimize the cost, time, and resource requirements of chemical synthesis and the biological testing of drugs. Also, these technologies provide the details of chemical and biological information about ligands and are being used to identify and optimize new drugs using computational techniques, which is further boosting the adoption of proteomics techniques in drug discovery applications. Additionally, the increase in continuous technological advancements in the proteomics product is one of the key developmental strategies adopted by the market players in the proteomics market. For instance, in June 2019 Bruker Corporation company introduced scimaXTM magnetic resonance mass spectrometer product (MRMS), at the ASMS (American Society for Mass Spectrometry).
In addition to this, in March 2017, ThermoFisher Scientific Incorporation launched iXR Raman Spectrometer for rapid and accurate chemical and structural analysis of genomics. Region-wise, North America is the strongest market for the proteomics market as the investments in the development of structure-based drug designs is increasing and also the government investments in genomics and proteomics research are considerably high in North America countries as compare to other countries. Moreover, the rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the major factors propelling the growth of the market in the North America region. However, the high cost associated with proteomics components and low biomarker discovery-to-approval ratio pose a threat to the growth of the proteomics market.
The research offers a comprehensive analysis of Proteomics market with respect to following sub-markets:
- - Microarray
- - Spectrometry
- - - - Mass Spectrometry
- - - - NMR Spectrometry
- - Chromatography
- - - - HPLC Systems
- - - - Ion Chromatography
- - - - Affinity Chromatography
- - - - Supercritical Fluid Chromatography
- - - - Others
- - - - X-ray Crystallography
- - - - Electrophoresis
- - - - Protein Fractionation Reagents
- - - - Others
- - - - laboratory services
- - - - Data analysis services
- Drug Discovery
- Disease Diagnosis
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)
The report profiles various major market players such as,
- Thermo Fisher Scientific Incorporation
- Agilent Technologies Incorporation
- GE Healthcare
- Bio-Rad Laboratories Incorporation
- Danaher Corporation
- Luminex Corporation
- Bruker Corporation
- Merck Group
- Waters Corporation
- Creative Proteomics
- Promega Corporation
- Others Prominent Players
Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as technology information, revenue breakup by segment and by geography, SWOT Analysis, risk analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development expansion and other market activities.
The study also provides company’s positioning and market share in Proteomics market.
Timeline Considered for Analysis:
- 2019- Base Year
- 2020 – Estimated Year
- 2020 to 2025 – Forecast Period
Research Scope and Deliverables:
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyzes the Proteomics market by the following segments:
- By Component
- By Application
Geographic Market Analysis:
The report offers separate analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In addition, further breakdown of market data and analysis of region into countries is covered in the report.
Customization: We also offers customization’s in the industry report as per the company’s specific needs.
Key Questions Answered in the Proteomics Market Industry Report:
- What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2025?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?
Custom Research Requirement? Questions to ask?Get in touch
Custom Research requirement.